Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RMAX
501
DELISTED
RE/MAX Holdings
RMAX
| $40M | 0.03% |
1,271,900
-1,300
| -0.1% | -$34.5K |
2015 Q1
21 quarters
|
|
502
National Health Investors
NHI
$3.17B
| $39.8M | 0.03% |
656,000
-362,200
| -36% | -$19.9M |
2017 Q1
13 quarters
|
|
503
FTI Consulting
FCN
$3.88B
| $39.7M | 0.03% |
346,749
+114,674
| +49% | +$13.9M |
2014 Q4
22 quarters
|
|
|
GNMK
504
DELISTED
GenMark Diagnostics, Inc
GNMK
| $39.3M | 0.03% |
2,673,500
+2,092,200
| +360% | +$21.3M |
2019 Q1
5 quarters
|
|
|
PXD
505
DELISTED
Pioneer Natural Resource Co.
PXD
| $39M | 0.03% |
399,488
+124,321
| +45% | +$11M |
2018 Q1
9 quarters
|
|
506
DNOW Inc
DNOW
$2.83B
| $38.9M | 0.03% |
4,507,508
+1,357,984
| +43% | +$9.33M |
2016 Q1
17 quarters
|
|
507
Cirrus Logic
CRUS
$5.67B
| $38.8M | 0.03% |
628,020
+57,562
| +10% | +$3.93M |
2019 Q3
3 quarters
|
|
|
MRO
508
DELISTED
Marathon Oil Corporation
MRO
| $38.7M | 0.03% |
6,320,421
+2,913,075
| +85% | +$16.1M |
2020 Q1
1 quarter
|
|
|
SAND
509
DELISTED
Sandstorm Gold
SAND
| $38.5M | 0.03% |
4,001,200
+562,300
| +16% | +$4.41M |
2019 Q1
5 quarters
|
|
510
Stewart Information Services
STC
$1.58B
| $38.3M | 0.03% |
1,179,097
+43,400
| +4% | +$1.31M |
2013 Q3
27 quarters
|
|
511
ATN International
ATNI
$438M
| $38.3M | 0.03% |
631,600
-9,300
| -1% | -$558K |
2016 Q2
16 quarters
|
|
512
Supernus Pharmaceuticals
SUPN
$2.45B
| $37.8M | 0.03% |
1,592,800
+690,600
| +77% | +$15.3M |
2017 Q4
10 quarters
|
|
513
Brookdale Senior Living
BKD
$2.6B
| $37.6M | 0.03% |
12,760,002
-529,200
| -4% | -$1.71M |
2017 Q4
10 quarters
|
|
|
ENIA
514
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $37.6M | 0.03% |
5,006,400
-835,600
| -14% | -$6.48M |
2015 Q3
19 quarters
|
|
515
J&J Snack Foods
JJSF
$1.53B
| $37.6M | 0.03% |
295,400
-35,050
| -11% | -$4.4M |
2013 Q2
28 quarters
|
|
516
CMS Energy
CMS
$20.5B
| $37.5M | 0.03% |
642,494
-1,115,121
| -63% | -$64.6M |
2016 Q1
17 quarters
|
|
517
McKesson
MCK
$108B
| $37.5M | 0.03% |
244,214
+110,888
| +83% | +$16M |
2020 Q1
1 quarter
|
|
518
American Public Education
APEI
$874M
| $37.5M | 0.03% |
1,265,693
+63,300
| +5% | +$1.77M |
2013 Q2
28 quarters
|
|
519
Extra Space Storage
EXR
$28.1B
| $37.4M | 0.03% |
405,336
-38,500
| -9% | -$3.58M |
2018 Q1
9 quarters
|
|
520
Genmab
GMAB
$22.2B
| $37.4M | 0.03% |
1,103,097
+954,697
| +643% | +$26M |
2020 Q1
1 quarter
|
|
521
Zebra Technologies
ZBRA
$18.1B
| $37.1M | 0.03% |
145,041
+55,310
| +62% | +$13M |
2019 Q4
2 quarters
|
|
|
CVGW
522
DELISTED
Calavo Growers
CVGW
| $37.1M | 0.03% |
589,820
+73,700
| +14% | +$4.42M |
2017 Q3
11 quarters
|
|
523
Sunstone Hotel Investors
SHO
$2.11B
| $37.1M | 0.03% |
4,552,431
-1,449,800
| -24% | -$12.6M |
2017 Q3
11 quarters
|
|
524
Orion
OEC
$329M
| $37.1M | 0.03% |
3,500,296
-673,324
| -16% | -$6.22M |
2015 Q1
21 quarters
|
|
525
Reinsurance Group of America
RGA
$16.7B
| $37M | 0.03% |
472,300
+142,800
| +43% | +$13.2M |
2018 Q4
6 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.